TEMP news

Latest 1 stories · newest Nov 18, 2026

TEMP
AstraZeneca extends multi-year Oncology Data Alliance

Tempus AI and AstraZeneca have finalized a Fifth Amendment to extend their strategic oncology collaboration through the Renewal Term starting January 1, 2027. This secures continued cooperation in drug discovery, data integration, and clinical operations.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same TEMP feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/TEMP/newsSTART FREE